首页> 外文期刊>Canadian Urological Association Journal >Technical feasibility of robot-assisted laparoscopic radical prostatectomy in renal transplant recipients: Results of a series of 12 consecutive cases
【24h】

Technical feasibility of robot-assisted laparoscopic radical prostatectomy in renal transplant recipients: Results of a series of 12 consecutive cases

机译:机器人辅助腹腔镜前列腺癌根治术在肾脏移植受者中的技术可行性:连续12例的结果

获取原文
       

摘要

Introduction: We evaluate the technical feasibility of robotic prostatectomy in renal transplant recipients. Methods: We retrospectively analyzed preoperative and perioperative settings, as well as functional and oncologic results of 12 patients operated on between 2009 and 2013. Prostatectomy was performed via a transperitoneal approach without any changing in the ports position. The average age was 61.92 ± 2.98 years. The period between transplant and the diagnosis of adenocarcinoma was 79.7 months. The mean PSA was 7.34 ng/mL (range: 4.9–11). Results: The operative time was 241.3 ± 35.6 minutes with only one conversion and one transfusion. The intervention was difficult due to adhesions on the side of the graft in 50% of cases. There was a case of obstructive acute renal failure resulting from a hematoma of the Retzius treated by percutaneous nephrostomy at D20. There was a majority of pT2c (72.7%), including 3 positive margins (27.3%) and 2 biochemical relapses treated with radiotherapy and hormonotherapy, respectively. The end point prostate-specific antigen was undetectable. There was no significant difference between preoperative and J7 creatinine ( p = 0. 22). Conclusions: Robotic prostatectomy in renal transplant recipients is a safe technique with no serious effects on the allograft.
机译:简介:我们评估了机器人前列腺切除术在肾移植受者中的技术可行性。方法:我们回顾性分析了2009年至2013年间12例手术患者的术前和围手术期设置以及功能和肿瘤学结果。前列腺切除术采用经腹膜入路进行,而端口位置未发生任何改变。平均年龄为61.92±2.98岁。从移植到诊断出腺癌的时间为79.7个月。平均PSA为7.34 ng / mL(范围:4.9-11)。结果:手术时间为241.3±35.6分钟,仅一次转换和一次输血。在50%的病例中,由于移植物侧面的粘附,很难进行干预。在第20天经皮肾造口术治疗的Retzius血肿引起阻塞性急性肾衰竭。 pT2c占大多数(72.7%),包括3个阳性切缘(27.3%)和2个经过放射疗法和激素疗法治疗的生化复发。无法检测到终点前列腺特异性抗原。术前和J7肌酐之间无显着差异(p = 0. 22)。结论:在肾移植受者中进行机器人前列腺切除术是一种安全的技术,对同种异体移植没有严重影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号